Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Garrett Motion Inc. | 16,592,384 | reported | 07 May 2021 | tx 1+380,952 |
| SAB Biotherapeutics, Inc. | 228,500 | reported | 22 Jul 2025 | tx 6+5,184,201−31,269 |
| Provention Bio, Inc. | 0 | reported | 27 Apr 2023 | tx 4+8,879,023−26,637,069 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 Jul 2025 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 114,250 | — | deriv |
| 22 Jul 2025 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 228,500 | — | deriv |
| 22 Jul 2025 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 228,500 | — | deriv |
| 24 Nov 2023 | EXERCISE | SAB Biotherapeutics, Inc. | 4,584,571 | — | |
| 24 Nov 2023 | EXERCISE | SAB Biotherapeutics, Inc. | 28,380 | 1000.00 USD | deriv |
| 24 Nov 2023 | EXERCISE | SAB Biotherapeutics, Inc. | 31,269 | 1000.00 USD | deriv |
| 27 Apr 2023 | TENDER | Provention Bio, Inc. | 15,567,497 | — | |
| 14 Apr 2023 | SALE | Provention Bio, Inc. | 2,190,549 | 24.32 USD | |
| 14 Apr 2023 | EXERCISE | Provention Bio, Inc. | 8,879,023 | 6.00 USD | |
| 14 Apr 2023 | EXERCISE | Provention Bio, Inc. | 8,879,023 | 0.00 USD | deriv |
| 07 May 2021 | PURCHASE | Garrett Motion Inc. | 380,952 | 5.25 USD | deriv |